Treprostinil-Based Therapy in the Treatment of Moderate-to-Severe Pulmonary Arterial Hypertension*: Long-term Efficacy and Combination With Bosentan
- 1 July 2008
- Vol. 134 (1) , 139-145
- https://doi.org/10.1378/chest.07-2111
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertensionEuropean Respiratory Journal, 2006
- Safety and Efficacy of Inhaled Treprostinil as Add-On Therapy to Bosentan in Pulmonary Arterial HypertensionJournal of the American College of Cardiology, 2006
- Effects of Long-Term Bosentan in Children With Pulmonary Arterial HypertensionJournal of the American College of Cardiology, 2005
- Treatment of Pulmonary Arterial HypertensionNew England Journal of Medicine, 2004
- Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2European Respiratory Journal, 2004
- Clinical classification of pulmonary hypertensionPublished by Elsevier ,2004
- Weaning and discontinuation of epoprostenol in children with idiopathic pulmonary arterial hypertension receiving concomitant bosentanThe American Journal of Cardiology, 2004
- Survival in Primary Pulmonary HypertensionCirculation, 2002
- Endothelial Dysfunction in the Pulmonary Vascular BedThe Lancet Healthy Longevity, 2000
- Nitric oxide: Its identity and role in blood pressure controlLife Sciences, 1995